Scribd Logo
Upload

Welcome to Scribd!

  • Executive Summary - ID-6

    Uploaded by

    azika
    21 views1 page
    This document summarizes the 2017 overall in vitro diagnostics (IVD) market in Indonesia, including market size and growth forecasts for various product segments. It also lists the top 4 competitors by market share for each segment. The largest segments by 2017 market size were clinical chemistry (IDR 488.2 billion), immunoassay (IDR 732.9 billion), and hematology (IDR 308.2 billion). Market growth rates between 2017-2022 were forecasted to be low for hematology, flow cytometry, urinalysis and point of care, and mid-range for most other segments. Notes provide additional context on market sizing methodology and definitions of growth rate levels.

    Original Description:

    Original Title

    Executive Summary_ID-6

    Copyright

    © © All Rights Reserved

    Available Formats

    PDF, TXT or read online from Scribd

    Did you find this document useful?

    Is this content inappropriate?

    Report this Document
    This document summarizes the 2017 overall in vitro diagnostics (IVD) market in Indonesia, including market size and growth forecasts for various product segments. It also lists the top 4 competitors by market share for each segment. The largest segments by 2017 market size were clinical chemistry (IDR 488.2 billion), immunoassay (IDR 732.9 billion), and hematology (IDR 308.2 billion). Market growth rates between 2017-2022 were forecasted to be low for hematology, flow cytometry, urinalysis and point of care, and mid-range for most other segments. Notes provide additional context on market sizing methodology and definitions of growth rate levels.

    Copyright:

    © All Rights Reserved
    Download as PDF, TXT or read online from Scribd
    Flag for inappropriate content
    Download as pdf or txt
    21 views1 page

    Executive Summary - ID-6

    Uploaded by

    azika
    This document summarizes the 2017 overall in vitro diagnostics (IVD) market in Indonesia, including market size and growth forecasts for various product segments. It also lists the top 4 competitors by market share for each segment. The largest segments by 2017 market size were clinical chemistry (IDR 488.2 billion), immunoassay (IDR 732.9 billion), and hematology (IDR 308.2 billion). Market growth rates between 2017-2022 were forecasted to be low for hematology, flow cytometry, urinalysis and point of care, and mid-range for most other segments. Notes provide additional context on market sizing methodology and definitions of growth rate levels.

    Copyright:

    © All Rights Reserved
    Download as PDF, TXT or read online from Scribd
    Flag for inappropriate content
    Download as pdf or txt
    of 1

    Overall Competitive Landscape

    Indonesia: 2017 Overall IVD Market Size

    ’17- ‘22 Competitors’ share ranking


    2017 market size
    Product segments forecasted
    (IDR bil)
    growth #1 #2 #3 #4

    Clinical Chemistry 488.2 Mid ROCHE MINDRAY SIEMENS TOKYO BUEKI

    Immunoassay 732.9 High ABBOTT ROCHE BIOMERIEUX DIASORIN

    Hematology 308.2 Low SYSMEX MINDRAY ABBOTT ABX

    Flow Cytometry 9.0 Low BD BECKMAN - -

    Blood grouping and typing 113.1 Mid CARLYLE GROUP BIO-RAD GRIFOLS TULIP

    Coagulation 54.1 High SYSMEX STAGO WERFEN -

    Microbiology 144.4 Mid BIOMERIEUX BD OXOID -

    Urinalysis 57.8 Low SYSMEX ROCHE DIRUI YD

    Point of Care 124.4 Mid ROCHE NOVA ALERE SIEMENS

    Molecular Diagnostics 84.8 Mid GRIFOLS ROCHE QIAGEN ABBOTT

    Tissue Diagnostics 24.2 High LEICA ROCHE THEMO-FISHER DAKO

    Notes
    - All market sizes are ex-manufacture price (not hospital buying price)
    - Assess hospital diagnostics only (includes samples sent to commercial labs from the hospital)
    - Molecular diagnostics (MDx) includes blood screening
    - Point-of-care testing (POC) includes blood gas & electrolytes, cardiac markers, hospital glucose testing, infectious diseases and others (including pregnancy tests,
    chemistry tests, drugs of abuse, hematology, HbA1c tests. Note GP clinics/clincis are excluded, only Hospital POC Diagnostics are included in this sizing.
    - Level of growth rates are defined as such: Low: 0-5%, Mid: 5.1-10%, High: 10.1-15% and Very High: >15%
    Sources: Clearstate interviews and analysis

    HEALTHCARE redefined: from INSIGHTS to STRATEGY 6

    You might also like